We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

87 hedge funds and large institutions have $190M invested in Antares Pharma, Inc. in 2013 Q2 according to their latest regulatory filings, with 87 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

70% less call options, than puts

Call options by funds: $650K | Put options by funds: $2.17M

Holders
87
Holders Change
+87
Holders Change %
–
% of All Funds
2.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
87
Increased
–
Reduced
–
Closed
–
Calls
$650K
Puts
$2.17M
Net Calls
-$1.52M
Net Calls Change
-$1.52M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$39.1M +$36.3M +9,400,000 New
O
2
OrbiMed
New York
$38.3M +$35.5M +9,199,000 New
BIT
3
BlackRock Institutional Trust
California
$14.4M +$13.4M +3,468,699 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$13.9M +$12.9M +3,339,806 New
BFA
5
BlackRock Fund Advisors
California
$11.7M +$10.9M +2,810,021 New
State Street
6
State Street
Massachusetts
$7.81M +$7.25M +1,877,092 New
WHI
7
William Harris Investors
Illinois
$7.07M +$6.56M +1,698,735 New
Northern Trust
8
Northern Trust
Illinois
$6.3M +$5.85M +1,515,102 New
Allianz Asset Management
9
Allianz Asset Management
Germany
$6.07M +$5.64M +1,460,155 New
TAM
10
THB Asset Management
Connecticut
$4.77M +$4.43M +1,146,100 New
UBS AM
11
UBS AM
Illinois
$3.69M +$3.42M +886,196 New
Fidelity Investments
12
Fidelity Investments
Massachusetts
$2.94M +$2.73M +706,700 New
Bank of New York Mellon
13
Bank of New York Mellon
New York
$2.67M +$2.48M +640,790 New
TCIM
14
TIAA CREF Investment Management
New York
$2.53M +$2.35M +607,311 New
KCM
15
Kingdon Capital Management
New York
$2.06M +$1.93M +500,000 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.01M +$1.87M +483,298 New
UOC
17
UBS O'Connor
Illinois
$1.98M +$1.83M +475,000 New
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$1.35M +$1.26M +325,400 New
BIM
19
BlackRock Investment Management
Delaware
$1.24M +$1.16M +299,123 New
AC
20
Avenir Corporation
Virginia
$1.15M +$1.07M +277,460 New
Invesco
21
Invesco
Georgia
$1.15M +$1.07M +277,000 New
Charles Schwab
22
Charles Schwab
California
$1.12M +$1.02M +263,809 New
MWR
23
McAdams Wright Ragen
Washington
$973K +$904K +234,000 New
AllianceBernstein
24
AllianceBernstein
Tennessee
$967K +$898K +232,498 New
ACM
25
Ashford Capital Management
Delaware
$943K +$875K +226,600 New
1
2 3 4

ATRS Hedge Fund Activity: Q2 2013 in Review

87 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2013, worth a combined $190M.

Buyers outnumbered sellers: 87 funds opened new ATRS positions and 0 closed out — a net gain of 87 holders — while 0 added to existing stakes and 0 trimmed.

  • 87 institutional investors held Antares Pharma, Inc. (ATRS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $190M of Antares Pharma, Inc. stock for Q2 2013.
  • 87 funds opened new Antares Pharma, Inc. positions in Q2 2013 and 0 closed out, a net change of +87 holders.

Based on aggregated 13F filings for Q2 2013.